Autoimmunity Can Change Female Hormones — What It Means

Credibility

Interest

Key Takeaway

In a rat model of MS-like disease, inflammation in the brain changed female reproductive hormones, keeping progesterone high while lowering ovarian estrogen and testosterone.

What They Found

The researchers gave rats a disease that mimics MS and watched the ovaries. During the worst part of the disease the rats stayed in a long resting phase of their cycle, like a month-long pause between periods. The ovaries kept structures that make progesterone, and progesterone levels inside the ovary were high, which is similar to a temporary pregnancy-like state. The proteins that help make testosterone and estrogen in the ovary were lower, and the ovary made less of those hormones. Blood levels of testosterone did not drop the same way, which suggests other body tissues might be making or breaking down hormones differently during the disease.

Who Should Care and Why

People with MS and their caregivers should know that inflammation in the brain can affect sex hormones and the reproductive system, not just the nerves. This matters because hormone changes can affect mood, energy, fatigue, and menstrual cycles—things many people with MS already worry about. Think of the body like a team: when the brain’s immune system is busy, other teammates (the ovaries and hormone makers) can change how they work. Doctors who treat MS and women's health may pay attention to hormone symptoms during flare-ups or treatment changes. Caregivers can support tracking cycle changes, mood shifts, and energy to help clinicians spot patterns and adjust care.

Important Considerations

This study was done in rats, not people, so results may not be exactly the same in women with MS. The study shows connections between brain inflammation and hormones, but it does not prove which change causes the other or how to treat it. More research in people is needed before changing treatments based on these findings.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression MS Genetics

Article Topics:

EAEmultiple sclerosisovariesprogesteronesteroidogenesistestosterone

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Cells often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News